About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker CORT

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 3, 202612778945
Treatments for Cushing's syndrome that do not significantly affect ca…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Sep 15, 202612735390
Pyrylium method of preparing pyrimidine cyclohexyl glucocorticoid rec…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jul 28, 202612691127
Use of glucocorticoid receptor antagonists in combination with glucoc…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jun 9, 202612648943
Treatment of adrenocortical carcinoma with selective glucocorticoid r…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
May 12, 202612625150
Treatment of, and differential diagnosis between, ACTH-dependent Cush…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
May 5, 202612616698
Methods for reducing liver fat and for treating fatty liver disorders
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
May 5, 202612616685
Concomitant administration of glucocorticoid receptor modulator relac…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Mar 31, 202612589094
Concomitant administration of glucocorticoid receptor modulator relac…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jan 6, 202612514849
Pharmaceutical formulations containing relacorilant, a heteroaryl-ket…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Oct 14, 202512440487
Method of normalizing the neutrophil to lymphocyte ratio in cancer pa…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Oct 7, 202512433882
Treatments for amyotrophic lateral sclerosis using dazucorilant
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jul 29, 202512370188
Formulations of dazucorilant, a glucocorticoid receptor modulator
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jul 29, 202512370175
Glucocorticoid receptor modulators to treat pancreatic cancer
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Jun 24, 202512336985
Methods for shrinking pituitary tumors
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
May 6, 202512290551
Methods for imaging and treatment of somatostatin-receptor positive t…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Apr 29, 202512285425
Glucocorticoid receptor modulators to treat cervical cancer
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Apr 1, 202512263169
Methods of treating neuroepithelial tumors using selective glucocorti…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Feb 18, 202512226417
Fatty liver disease treatment using glucocorticoid and mineralocortic…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Feb 18, 202512226412
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Dec 31, 202412180186
Quaternary indazole glucocorticoid receptor antagonists
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Dec 24, 202412171760
Use of glucocorticoid receptor modulators to potentiate checkpoint in…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Nov 26, 202412152028
Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoi…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Nov 19, 202412144812
Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulat…
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Nov 12, 202412139486
Octahydro fused azadecalin glucocorticoid receptor modulators
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗
Nov 12, 202412139463
Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators
CORT
Corcept Therapeutics Incorporated
utilityGoogle Patents ↗

25 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:22 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances